IMO… it is a mistake to “try to increase U.S. competitiveness through protectionism.” The new rule “may make it easier for non-U.S. companies to succeed through manufacturing in China. This wouldn’t help our global competitiveness.” IMO… let’s instead kick ass with American ingenuity! biocentury.com/article/66129…

Thanks for asking @jrkelly. It highlights why you and your hawks are not quite getting it here. This is about finding the best innovation for patients from anywhere in the world. I fully expect the cost of developing these assets in the U.S. will be largely the same. For e.g., the Akeso/Summit anti-PD1/VEGF bispecific was discovered in China. Summit was excited about the data and in-licensed it for ex-China rights. Summit is doing robust global clinical studies to demonstrate safety and efficacy. If successful, American patients will get access to a best-in-class immunotherapy that could be a game changer. To my knowledge, there wasn’t an alternative PD1-VEGF bispecific discovered in the U.S. Also, there was no stealing of IP by Akeso to make their drug. Why is this different than Merck sourcing Keytruda from Belgium? So, let’s not use walls to block access to innovation from ANYWHERE in the world especially when it can help US patients. Of course, IP MUST be respected, or the “discovery” is a violation of international law. To clarify one other point, I also want the U.S. to be the indisputable global leader in biotechnology! China’s increased prominence must be a SPUTNIK moment for our country. We should reverse the self-inflicted damage to our innovation ecosystem that includes decimated NIH funding, an anti-science/anti-vaccine/anti-“expert” rhetoric that threatens discourse, a restricted H-1B visa program blocking our ability to recruit the best in the world, a chaotic FDA where innovators and drug developers face enormous uncertainty and undue regulatory hurdles and costs, an effort to break our innovation reward system with drug price controls through Biden-era IRA and Trump-era MFN, a post-COVID hybrid workforce approach that has American’s working less, and more. I, for one, believe that we can WIN with good ole American ingenuity if we course correct on the above. I’m certain that will work. We have the greatest scientists in the world and lead in disruptive innovation while others are making progress in incremental innovation. For those of you that advocate for walls, I don’t think it will be successful. AND, I’m certain American patients will suffer. My $0.02.